Literature DB >> 19711065

Role of scanning electron microscopy in identifying drugs used in medical practice.

Y M Fazil Marickar1, N Sylaja, Peter Koshy.   

Abstract

Several plant preparations are administered for treatment of stone disease without scientific basis. This paper presents the results of in vitro and animal experimental studies using scanning electron microscopy (SEM) in the identification of the therapeutic properties of trial drugs in medicine. In the first set of the study, urinary crystals namely calcium oxalate monohydrate and calcium oxalate dehydrate were grown in six sets of Hane's tubes in silica gel medium. Trial drugs namely scoparia dulcis Lynn, musa sapiens and dolicos biflorus were incorporated in the gel medium to identify the dopant effect of the trial drugs on the size and extent of crystal column growth. The changes in morphology of crystals were studied using SEM. In the second set, six male Wistar rats each were calculogenised by administering sodium oxalate and ethylene glycol and diabetised using streptozotocin. The SEM changes of calculogenisation were studied. The rats were administered trial drugs before calculogenisation or after. The kidneys of the rats studied under the scanning electron microscope showed changes in tissue morphology and crystal deposition produced by calculogenisation and alterations produced by addition of trial drugs. The trial drugs produced changes in the pattern of crystal growth and in the crystal morphology of both calcium oxalate monohydrate and calcium oxalate dihydrate grown in vitro. Elemental distribution analysis showed that the crystal purity was not altered by the trial drugs. Scoparia dulcis Lynn was found to be the most effective anticalculogenic agent. Musa sapiens and dolicos biflorus were found to have no significant effect in inhibiting crystal growth. The kidneys of rats on calculogenisation showed different grades of crystals in the glomerulus and interstitial tissues, extrusion of the crystals into the tubular lumen, collodisation and tissue inflammatory cell infiltration. Scoparia dulcis Lynn exhibited maximum protector effect against the changes of calculogenisation. Musa sapiens and dolicos biflorus had only minimal effect in preventing crystal deposition, inflammatory cell infiltration and other changes of calculogenisation. SEM was found to be effective in assessing the effect of drugs on crystal growth morphology and tissue histology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19711065     DOI: 10.1007/s00240-009-0212-6

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  11 in total

Review 1.  Intratubular crystallization events.

Authors:  D J Kok
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

Review 2.  The definition of the mechanism of hypercalciuria is necessary for the treatment of recurrent stone formers.

Authors:  C Y Pak; M Nicar; C Northcutt
Journal:  Contrib Nephrol       Date:  1982       Impact factor: 1.580

3.  The renal papilla and calculogenesis.

Authors:  C W Vermeulen; E S Lyon; J E Ellis; T A Borden
Journal:  J Urol       Date:  1967-04       Impact factor: 7.450

4.  Calcium oxalate nephrolithiasis: effect of renal crystal deposition on the cellular composition of the renal interstitium.

Authors:  R de Water; C Noordermeer; T H van der Kwast; H Nizze; E R Boevé; D J Kok; F H Schröder
Journal:  Am J Kidney Dis       Date:  1999-04       Impact factor: 8.860

5.  Oxalate toxicity in LLC-PK1 cells: role of free radicals.

Authors:  C Scheid; H Koul; W A Hill; J Luber-Narod; L Kennington; T Honeyman; J Jonassen; M Menon
Journal:  Kidney Int       Date:  1996-02       Impact factor: 10.612

6.  Effect of Crataeva nurvala in experimental urolithiasis.

Authors:  P Varalakshmi; Y Shamila; E Latha
Journal:  J Ethnopharmacol       Date:  1990-03       Impact factor: 4.360

Review 7.  Symposium on renal lithiasis. Renal lithiasis in review.

Authors:  B Finlayson
Journal:  Urol Clin North Am       Date:  1974-06       Impact factor: 2.241

8.  Etiology of calcium oxalate nephrolithiasis in rats. I. Can this be a model for human stone formation?

Authors:  W C de Bruijn; E R Boevé; P R van Run; P P van Miert; R de Water; J C Romijn; C F Verkoelen; L C Cao; F H Schröder
Journal:  Scanning Microsc       Date:  1995-03

9.  Calcium oxalate monohydrate binding protein: a diagnostic biomarker for calcium oxalate kidney stone formers.

Authors:  D Asokan; P Kalaiselvi; S Muhammed Farooq; P Varalakshmi
Journal:  Urol Res       Date:  2004-09-07

10.  The renal lesions of electrolyte imbalance. IV. The intranephronic calculosis of experimental magnesium depletion.

Authors:  J Oliver; M MacDowell; R Whang; L G Welt
Journal:  J Exp Med       Date:  1966-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.